BFM 89.9
The Business Station
Biosimilars In Cancer Care and Why They Matter
37 mins·16:00, 7 May 2026
Biosimilars In Cancer Care and Why They Matter
37 mins
·
16:00, 7 May 2026
·
Recommended
26 mins
23 mins
26 mins
Guest: Dr Mark Cheong, Pharmacist and Public Health Researcher
Innovator drugs and treatments can be costly, even if they are life-saving in cases of chronic and serious illnesses like cancer. That’s where generic and biosimilar drugs come in, offering patients more affordable alternatives. But how exactly do generics and biosimilars work? Are they as effective? We speak to pharmacist and public health researcher, Dr Mark Cheong to find out.
Image Credit: Shutterstock
Presenter: Lim Sue Ann
Producer: Lim Sue Ann
genericsinnovator drugsthe bigger picturehealth & livingcanceroncologybiologicsbiosimilarspatentshealthcare accessibility
Share:
Recommended
May 10
·
23 minsWhat It Takes To Get Your Bread Right
May 9
·
26 minsConfronting Bullying In The Workplace
Recent episodes
0
Latest stories
Podcasts · May 7 · 10:00AM
Do You Enjoy Travelling Solo or With Company?
1 hr 4 mins
Podcasts · May 7 · 1 hr 4 mins
Do You Enjoy Travelling Solo or With Company?
Podcasts · May 7 · 9:00AM
Top 5 at 5: How Climate Change Can Shrink Malaysia's GDP
40 mins
Podcasts · May 7 · 40 mins
Top 5 at 5: How Climate Change Can Shrink Malaysia's GDP
Podcasts · May 7 · 8:00AM
Biosimilars In Cancer Care and Why They Matter
37 mins
Podcasts · May 7 · 37 mins
Biosimilars In Cancer Care and Why They Matter